scispace - formally typeset
A

Axel Ullrich

Researcher at Max Planck Society

Publications -  436
Citations -  63142

Axel Ullrich is an academic researcher from Max Planck Society. The author has contributed to research in topics: Receptor tyrosine kinase & Tyrosine kinase. The author has an hindex of 124, co-authored 436 publications receiving 61445 citations. Previous affiliations of Axel Ullrich include Institute of Molecular and Cell Biology & Agency for Science, Technology and Research.

Papers
More filters
Journal ArticleDOI

Smart drugs: tyrosine kinase inhibitors in cancer therapy.

TL;DR: A postgenomic wave of sophisticated "smart drugs" to fundamentally change the treatment of all cancers is anticipated, and interest in this new class of therapeutics extends from basic research scientists to practicing oncologists and their patients.
Journal ArticleDOI

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

TL;DR: The recent identification of Zn2+-dependent metalloproteinases and transmembrane growth factor precursors as critical elements in GPCR-induced EGFR transactivation pathways has defined new components of a cellular communication network of rapidly increasing complexity.
Journal ArticleDOI

Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body

TL;DR: It is concluded that sorting of internalized receptor for degradation or recycling can occur through spatial segregation within the MVB, and sorting of EGF-R is controlled by tyrosine kinase activity.
Journal ArticleDOI

Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth

TL;DR: A panel of monoclonal antibodies specific to the extracellular portion of the ERBB2 protein was generated and it was suggested that the antitumor antibodies affect both receptor function and host-tumor interactions.
Journal ArticleDOI

EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor.

TL;DR: In this article, the authors examined whether the differential activation of MAP kinases forms the basis of the differential response of the cells to the two factors, and they found that the distinct effects of nerve growth factor and epidermal growth factor on PC12 cell differentiation can be explained by differences in the extent and duration of activation of p42 and p44 MAP kinase in response to two factors.